Home » Topics » BioWorld Science, Nephrology

BioWorld Science, Nephrology
RSS

TH-070 fails to meet endpoint in BPH phase II and phase III trials

July 19, 2006

Anti-PDGF-D monoclonal antibody may help delay mesangioproliferative nephritis progression

July 17, 2006

Sanctura XR reduces overactive bladder symptoms with good tolerability

July 11, 2006

First collaborative compound from Actelion and Merck renin alliance enters clinic

July 7, 2006

Micardis filed in Japan for type 2 diabetic nephropathy

July 5, 2006

Novel norepinephrine and serotonin reuptake inhibitors imparted by Pfizer

July 4, 2006

Zerenex shows utility as treatment for hyperphosphatemia in hemodialysis patients

July 3, 2006

No safety concerns in phase II BPH study of NX-1207

June 30, 2006

End of phase II meeting for Anturol

June 29, 2006

Schering AG terminates Alprox-TD license with NexMed

June 29, 2006

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 15, 2026.
ASGCT 2026: Circular RNA, the new beast in gene and cell therapy
BioWorld
Circular RNA (circRNA) is not a new concept, but it is a novel strategy in the field of gene and cell therapy. While mRNA vaccines have revolutionized medicine,...
Advancing the 'best of both' – BMS, Hengrui enter $15.2B deal
BioWorld
In a deal potentially worth up to $15.2 billion, Jiangsu Hengrui Pharmaceuticals Co. Ltd. is joining efforts with Bristol Myers Squibb Co. to advance 13 early...
News in brief
BioWorld Asia
BioWorld Asia briefs for May 12, 2026
ASGCT 2026: Uncovering the mechanisms of AAV toxicity
BioWorld
Gene therapies rely on vectors to reach the target tissue where they act, such as adeno-associated viruses (AAVs) or lipid nanoparticles (LNPs), among other...